Markets:

Overview

News

Currencies

International

Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

6.370 -0.430 (-6.32%)

Streaming Delayed Price Updated: 2:14 PM EDT, Apr 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

A Preview Of OptimizeRx's Earnings ↗

March 07, 2023

Via Benzinga

OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET

February 23, 2023

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars

February 09, 2023

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference

January 04, 2023

From OptimizeRx Corporation

Via GlobeNewswire

Analyst Ratings for OptimizeRx ↗

November 01, 2022

Within the last quarter, OptimizeRx (NASDAQ:OPRX) has observed the following analyst ratings:

Via Benzinga

OptimizeRx to Participate in Upcoming Investor Conferences

November 28, 2022

From OptimizeRx Corporation

Via GlobeNewswire

Nasdaq Drops 200 Points; Meta Platforms Shares Jump ↗

November 09, 2022

U.S. stocks traded lower toward the end of trading , with the Nasdaq Composite dropping 200 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 09, 2022

Gainers

Via Benzinga

Crude Oil Down Over 2%; Outset Medical Shares Spike Higher ↗

November 09, 2022

U.S. stocks traded lower midway through trading as investors focused on the outcome of the midterm elections.

Via Benzinga

Expert Ratings for OptimizeRx ↗

August 10, 2022

Analysts have provided the following ratings for OptimizeRx (NASDAQ:OPRX) within the last quarter:

Via Benzinga

Macro Factors Behind OptimizeRx's Weaker Than Expected Q2 Earnings, Lowers Annual Guidance ↗

August 10, 2022

Via Benzinga

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗

November 10, 2022

Gainers

Via Benzinga

Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session ↗

November 09, 2022

Gainers

Via Benzinga

Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday ↗

November 09, 2022

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

OptimizeRx Reports Third Quarter 2022 Financial Results

November 08, 2022

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event

October 20, 2022

Virtual event takes place December 1, 2022

From OptimizeRx Corporation

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET

October 19, 2022

From OptimizeRx Corporation

Via GlobeNewswire

OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution

October 11, 2022

Analysis demonstrates effectiveness of OptimizeRx’s real-world evidence solution to identify patients suitable for a specialty therapy within a narrow timeframe

From OptimizeRx Corporation

Via GlobeNewswire

How Is The Market Feeling About OptimizeRx? ↗

August 15, 2022

OptimizeRx's (NASDAQ:OPRX) short percent of float has fallen 12.86% since its last report. The company recently reported that it has 1.22 million shares sold short,...

Via Benzinga

Here's How Much $100 Invested In OptimizeRx 5 Years Ago Would Be Worth Today ↗

August 15, 2022

OptimizeRx (NASDAQ:OPRX) has outperformed the market over the past 5 years by 54.86% on an annualized basis producing an average annual return of 66.88%. Currently, OptimizeRx has a market...

Via Benzinga

Nasdaq Surges Over 300 Points; Trade Desk Shares Spike Higher ↗

August 10, 2022

U.S. stocks traded higher toward the end of trading, following the release of inflation data.

Via Benzinga

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 10, 2022

Via Benzinga

Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session ↗

August 10, 2022

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.

Via Benzinga

Dow Jumps 500 Points; Crude Oil Down 1% ↗

August 10, 2022

U.S. stocks traded higher midway through trading, following the release of inflation data.

Via Benzinga

WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday ↗

August 10, 2022

OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 10, 2022

During Wednesday, 52 stocks hit new 52-week lows.

Via Benzinga

11 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 10, 2022

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 10, 2022

It's time for another dive into the biggest pre-market stock movers as we check out the latest news for Wednesday morning!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.